# Molina Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2022

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-K
- Filed: 2023-02-13
- Accepted by EDGAR: Feb 13, 2023, 16:22 ET
- Period: 2022-12-31
- Accession: 0001179929-23-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000025/moh-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992923000025/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $31.97bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $27.18bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | $1.17bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2022-01-01 to 2022-12-31 | $110.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | $271.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | $792.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | $13.55 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | $13.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2022-01-01 to 2022-12-31 | 58,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | $773.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $91.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2022-01-01 to 2022-12-31 | $400.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-12-31 | $4.01bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-12-31 | $10.08bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $12.31bn | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $6.86bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-12-31 | $9.35bn | us-gaap:Liabilities |
| Long-term debt | at 2022-12-31 | $2.18bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2022-12-31 | $2.96bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992923000025/moh-20221231.htm

Filed Feb 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001179929-23-000025. Last ingested by Listed: Nov 15, 2026, 00:39 ET. No prices; not investment advice.
